Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns

Pharmacology for Nurses40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns

Learning Outcomes

By the end of this section, you should be able to:

  • 40.4.1 Identify the characteristics of drugs used to treat miscellaneous dermatologic disorders and burns.
  • 40.4.2 Explain the indications, actions, adverse reactions, and interactions of drugs used to treat miscellaneous dermatologic disorders and burns.
  • 40.4.3 Describe nursing implications of drugs used to treat miscellaneous dermatologic disorders and burns.
  • 40.4.4 Explain the client education related to drugs used to treat miscellaneous dermatologic disorders and burns.

In addition to acne and psoriasis, there are other common skin conditions for which clients may receive treatment. In this chapter they are divided into miscellaneous dermatologic conditions and burns.

Miscellaneous Dermatologic Disorders

This section focuses on the most common dermatological disorders not yet discussed, including cutaneous warts, atopic dermatitis (eczema), contact dermatitis, impetigo, and rosacea.

Cutaneous Warts

Cutaneous warts are a form of localized viral infection, resulting in the familiar raised lesions known as warts (Figure 40.5). Current therapies in the treatment of warts include medications that chemically burn these lesions, thus eliminating them. Cantharidin is one such drug. As a vesicant, cantharidin causes local tissue necrosis on those surfaces to which it is applied. This necrosis will eventually result in the sloughing of the wart and elimination of the virus.

A closeup photo of an eyelid with a wart on it. The wart is a small cluster of rough looking skin.
Figure 40.5 A cutaneous wart has an irregular shape and surface. (credit: “Filiform wart on the eyelid” by Schweintechnik/Wikimedia Commons, Public Domain)

Atopic Dermatitis (Eczema)

Atopic dermatitis (eczema) is another skin condition that requires pharmacological treatment. Unlike conditions characterized solely by local irritation, atopic dermatitis is a systemic disease that has genetic predispositions, involves the immune system, and also has environmental influences. This condition has also been linked to other disorders, including asthma and hay fever (National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2022). The etiology is not clearly understood, but treatment involves using oral and topical medications to relieve the characteristic lesions of atopic dermatitis (Figure 40.6). Hydrocortisone and pimecrolimus are often used topically to treat atopic dermatitis.

A closeup photo of skin with eczema shows small, scaly, enflamed patches on the skin.
Figure 40.6 Atopic dermatitis/eczema characteristically appears as red, dry patches. (credit: “This image depicts a close view of a cutaneous lesion known as nummular eczema, which also goes by the names nummular dermatitis, or discoid eczema, which presents itself as round [PHIL 16526], or oval-shaped erythematous, itchy patches” by Susan Lindsley/Centers for Disease Control and Prevention, Public Domain)

Contact Dermatitis

Contact dermatitis is an acute inflammation caused by aggravating factors that results in swollen, red, itchy lesions (Figure 40.7). Substances that may cause contact dermatitis include, but are not limited to, soaps, cosmetics, jewelry, and poison ivy/oak. Treatment focuses on decreasing inflammation and providing comfort and decreased pain and itching. Hydrocortisone, when applied to areas of contact dermatitis, acts to decrease inflammation, relieving the red, warm, edematous symptoms. In addition to hydrocortisone or other corticosteroid ointments, calamine lotion also may be used to reduce itching and promote healing. This solution is made by combining zinc oxide and ferric oxide, which, when applied to the skin, soothes the affected area and reduces itching and burning at the site.

A closeup photo of an arm with contact dermatitis shows a large enflamed rash.
Figure 40.7 Contact dermatitis is acute inflammation resulting from direct contact with irritants. (credit: “This photograph depicts an individual’s arm with a blistering poison oak rash.”/Centers for Disease Control and Prevention, Public Domain)

Impetigo

Impetigo is a cutaneous bacterial infection that occurs on the upper surface of the skin (Figure 40.8). Typically, impetigo is seen in infants and children, although it may occasionally be seen in adults. The causative organisms are most often Staphylococcus aureus and Streptococcus pyogenes bacteria. Treatment encompasses application of mupirocin, a topical antibacterial. Retapamulin, another topical anti-infective used in impetigo, selectively inhibits protein synthesis to stop bacterial growth. Topical treatment with these agents usually clears impetigo, but if impetigo persists and is severe, oral antibiotics may be needed.

A closeup photo of an arm with impetigo shows small, round pustules, as well as some that have erupted and scabbed over.
Figure 40.8 Impetigo is characterized by vesicles, pustules, or bullae that rupture, producing sores covered by honey-colored crusts. (credit: “The lesions on the volar surface of this patient’s left forearm proved to be Streptococcal impetigo, a dermatologic condition quite often caused by Staphylococcus aureus bacteria, as well” by Dr. Herman Miranda, Univ.of Trujello, Peru; A. Chambers/Centers for Disease Control and Prevention, Public Domain)

Rosacea

Rosacea is a skin condition that develops from an inflammatory process, causing redness, swelling, prominent small vessels, and papular lesions on the face (Figure 40.9). Metronidazole, an antifungal, is used in the treatment of rosacea to reduce redness and inflammatory lesions. Nurses should note that when absorbed systemically, metronidazole interacts negatively with many other medicines. When alcoholic beverages are mixed with metronidazole, a life-threatening disulfiram-like reaction may occur, resulting in palpitations, diaphoresis, flushing, nausea, and tachycardia (Stokes & Abdijadid, 2019). Sodium sulfacetamide, another treatment for rosacea, is antibacterial in function and is used to cleanse the skin and eliminate bacteria. Clients with sulfa allergies should not use sodium sulfacetamide.

A closeup photo of a face with rosacea. The nose and cheek area is a deep red color, and there are some swollen red bumps as well.
Figure 40.9 Rosacea, consisting of red bumps and broken blood vessels, occurs on the face. (credit:“Rosacea. Erythema and telangiectasia are seen over the cheeks, nasolabial area and nose. Inflammatory papules and pustules can be observed over the nose. The absence of comedos is a helpful tool to distinguish rosacea from acne.” by Sand, M., Sand, D., Thrandorf, C. et al. “Cutaneous lesions of the nose.” Head Face Med 6, 7 [2010]. https://doi.org/10.1186/1746-160X-6-7/BioMed Central, CC BY 2.0)

Table 40.11 lists common miscellaneous dermatologic drugs and typical routes and dosing for adult and pediatric clients.

Drug Routes and Dosage Ranges
Hydrocortisone
(Cortef)
Adults and children >2 years: Apply 1% cream topically to affected area 3 times daily.
Methylprednisolone
(Medrol)
Adults: 4–48 mg/day orally, depending on the specific disease entity being treated.
Calamine lotion
(Calananz)
Adults and children >2 years: Apply to area as needed, let dry.
Retapamulin
(Altabax)
Adults: Apply a thin layer to the affected area (not to exceed 100 cm2) twice daily for 5 days.
Children ≥9 months: Apply a thin layer on areas not to exceed 2% total body surface area twice daily for 5 days.
Mupirocin
(Bactroban)
Adults and children >2 months: Apply ointment (2%) to area 2–3 times daily.
Metronidazole
(Flagyl)
Adults: Apply gel (0.75%) topically and rub in a thin film twice daily, morning and evening.
Children: Safety and effectiveness in pediatric clients have not been established.
Sodium sulfacetamide
(Sumaxin, Cetamide)
Adults: Wash affected areas with 10% gel twice daily (morning and evening) or as directed by your physician.
Children: Safety and effectiveness in children under 12 years has not been established.
Pimecrolimus
(Elidel)
Adults and children >2 years: Apply a thin layer of 1% cream to affected areas twice daily.
Cantharidin
(Yanth)
Adults and children >2 years: Apply topically to wart surface only; repeat every 3 weeks as needed.
Table 40.11 Drug Emphasis Table: Other Dermatologic Drugs (source: https://dailymed.nlm.nih.gov/dailymed/)

Safety Alert

Topical Steroids

When using topical steroids, the application sites should not be covered with an occlusive dressing. Breathable gauze dressings may be used. Topical corticosteroids are meant to exert a local effect; however, when these medications are covered with an occlusive dressing, systemic absorption may occur, leading to systemic side effects of the drug.

Adverse Effects and Contraindications

Adverse effects associated with topical medications for skin disorders include hypersensitivities. This is especially associated with mupirocin. Localized irritation, redness, and peeling may be noted with these medications as well. When covered with occlusive dressings, clients may experience systemic absorption, resulting in the likelihood of systemic effects. For this reason, occlusive dressings are contraindicated.

Steroid compounds are contraindicated in fungal infections. Long-term use of pimecrolimus, a calcineurin inhibitor, has been associated with the development of lymphomas. For this reason, long-term use is contraindicated.

Table 40.12 is a drug prototype table for common dermatologic medications featuring mupirocin. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Topical antibiotic

Mechanism of Action
Bactericidal; binds RNA transcription
Drug Dosing
Adults and children >2 months: Apply ointment (2%) to area 2–3 times daily.
Indications
Impetigo

Therapeutic Effects
Eradication of impetigo lesions
Drug Interactions
Other topical medications used concurrently

Food Interactions
No significant interactions
Adverse Reactions
Atopic dermatitis
Contact dermatitis
Pruritis
Hypersensitivities including anaphylaxis
Contraindications
Hypersensitivity

Caution:
Avoid occlusive dressings to prevent systemic
absorption
Table 40.12 Drug Prototype Table: Mupirocin (source: https://dailymed.nlm.nih.gov/dailymed/)

Topical Anti-infectives for Burns

The greatest risk from minor burns is infection. Because a burn removes layers of skin, an open lesion forms, breaking the skin’s integrity and allowing bacteria and other organisms to enter the client’s body. Silver sulfadiazine and mafenide acetate are two topical anti-infectives used in the treatment and prevention of infection for localized second- and third-degree burns. As with sodium sulfacetamide, these medications are sulfa compounds that should not be administered to those with sulfa allergies. The nurse should take care to maintain a sterile environment when applying these medications to aid in preventing bacterial transfer to the client. To remain effective, burns should be completely covered with cream at all times to prevent bacterial colonization (DailyMed, Sulfamylon, 2023).

Table 40.13 lists common topical medications used in treating burns with typical routes and dosing for adult and pediatric clients.

Drug Routes and Dosage Ranges
Mafenide acetate
(Sulfamylon)
Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately 116116 inch.
Silver sulfadiazine
(Silvadene)
Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately 116116 inch.
Table 40.13 Drug Emphasis Table: Topical Anti-infectives for Burns (source: https://dailymed.nlm.nih.gov/dailymed/)

Adverse Effects and Contraindications

Adverse effects associated with topical medications for burns include hypersensitivities, pruritis, localized irritation, redness, and peeling. When covered with occlusive dressings, clients may experience systemic absorption, resulting in the likelihood of systemic effects. For this reason, occlusive dressings are contraindicated. Contraindications include hypersensitivities to drugs or their components.

Table 40.14 is a drug prototype table for common burn treatments featuring silver sulfadiazine. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

Drug Class
Topical antibiotic

Mechanism of Action
Bactericidal; disrupts cell wall
Drug Dosing
Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately 116116 inch.
Indications
Second- and third-degree burns

Therapeutic Effects
Absence of infectious organisms in wound bed
Drug Interactions
Other topical medications used concurrently
Cimetidine

Food Interactions
No significant interactions
Adverse Reactions
Hypersensitivities
Necrosis
Erythema multiforme
Skin discoloration
Burning sensation
Rashes
Interstitial nephritis
Leucopenia
Contraindications
Hypersensitivity
Sulfa allergy
Pregnant clients approaching or at term
Premature infants or newborn infants during the first 2 months of life
Table 40.14 Drug Prototype Table: Silver Sulfadiazine (source: https://dailymed.nlm.nih.gov/dailymed/)

Safety Alert

Silver Sulfadiazine

Silver sulfadiazine is widely used for burns with low risk of adverse effects. Overdose is uncommon, but systemic absorption can still occur. Care should be taken when applying the medication near mucosal or ocular areas or when it is used over a large body surface area.

(Source: Oaks & Cindass, 2023)

Nursing Implications

The nurse should do the following for clients who are using drugs for the treatment of burns:

  • Conduct vigilant assessments for baseline, response to treatment, adverse effects, infection, and systemic absorption.
  • Monitor creatinine for decreased renal function from possible effects of systemic absorption.
  • Observe for hypersensitivity reactions during and after administration.
  • Apply topical medications with gloves.
  • Maintain aseptic technique when applying medications.
  • Emphasize the importance of compliance with instructions and follow up with clients when necessary.
  • Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.

Client Teaching Guidelines

The client using a topical medication for burns should:

  • Take prescribed medications exactly as directed.
  • Wash hands well before and after application.
  • Report side effects such as skin redness, excessive dryness, or peeling to the primary provider.
  • Report drainage, odor, temperature above 100.4°F, or other unusual symptoms to the primary provider.
  • Cleanse skin thoroughly before applying medication.
  • Avoid contact with eyes and mucous membranes.

The client using a topical medication for burns should not:

  • Cover the medication with occlusive dressings.

FDA Black Box Warning

Pimecrolimus

Pimecrolimus cream has been associated with skin malignancies and lymphoma. Continuous long-term use should be avoided in any age group. Its use is not indicated for children less than 2 years of age.

Case Study

Read the following clinical scenario to answer the questions that follow.

Within the last year, Melissa Allen, a 27-year old patient, has gotten married, moved to a new city, and begun graduate school. Recently, she has noticed feeling a little more tired than usual and has experienced generalized joint pain.

History
Right ankle fracture
Seasonal sinusitis

Current Medications
Ibuprofen, 400 mg every 4 hours as needed
Yasmin birth control pill (drospirenone 3 mg/ethinyl estradiol 0.03 mg)

Vital Signs Physical Examination
Temperature: 97.4°F
  • Head, eyes, ears, nose, throat (HEENT): Denies any changes in vision; responds to questions appropriately without requests for repeats
  • Neurological: Alert and oriented × 4, pleasant affect; denies numbness, tingling, dizziness, or headache
  • Cardiovascular: Regular heart rate and rhythm; denies palpitations; S1, S2 audible; no extra sounds noted; capillary refill +3; mucous membranes pink, moist, and intact
  • Respiratory: Lungs clear to auscultation in all fields; denies shortness of breath
  • GI: Abdomen soft, nontender, without distention; bowel sounds active in all quadrants; denies nausea, vomiting, diarrhea, or constipation
  • GU: Last menstrual period 16 days ago
  • Integumentary: Nails with cracking noted; scalp with excessive silvery scaling and reddened areas noted; skin intact to limbs and trunk except for small scaling; red areas noted bilaterally on elbows; client states she has noticed more “itching and dandruff” lately
Blood pressure: 126/64 mm Hg
Heart rate: 88 beats/min
Respiratory rate: 14 breaths/min
Oxygen saturation: 100% on room air
Pain: 3/10
Height: 5'5"
Weight: 144 lb
Table 40.15
1.
Based on Melissa’s subjective and objective assessment data, what diagnosis should the nurse anticipate from the health care provider?
  1. Acne vulgaris
  2. Psoriasis
  3. Impetigo
  4. Rosacea
2.
The health care provider prescribes topical coal tar. Which statement by Melissa indicates a need for further teaching from the nurse regarding the use of topical coal tar?
  1. “I guess this means that I will need to cancel my tanning bed membership.”
  2. “I should cover the surrounding margins of lesions with a thick coat of medication.”
  3. “I will wash my skin, apply the medication, and leave it open to the air.”
  4. “I will refrain from using the medication on my face, especially near my eyes.”
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.